1. Home
  2. SWAG vs CYTH Comparison

SWAG vs CYTH Comparison

Compare SWAG & CYTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SWAG
  • CYTH
  • Stock Information
  • Founded
  • SWAG 1994
  • CYTH 1990
  • Country
  • SWAG United States
  • CYTH United States
  • Employees
  • SWAG N/A
  • CYTH N/A
  • Industry
  • SWAG Advertising
  • CYTH Biotechnology: Pharmaceutical Preparations
  • Sector
  • SWAG Consumer Discretionary
  • CYTH Health Care
  • Exchange
  • SWAG Nasdaq
  • CYTH Nasdaq
  • Market Cap
  • SWAG 20.2M
  • CYTH 20.4M
  • IPO Year
  • SWAG 2021
  • CYTH N/A
  • Fundamental
  • Price
  • SWAG $1.18
  • CYTH $0.71
  • Analyst Decision
  • SWAG
  • CYTH Buy
  • Analyst Count
  • SWAG 0
  • CYTH 3
  • Target Price
  • SWAG N/A
  • CYTH $0.95
  • AVG Volume (30 Days)
  • SWAG 12.3K
  • CYTH 23.7K
  • Earning Date
  • SWAG 11-26-2024
  • CYTH 11-14-2024
  • Dividend Yield
  • SWAG N/A
  • CYTH N/A
  • EPS Growth
  • SWAG N/A
  • CYTH N/A
  • EPS
  • SWAG 0.00
  • CYTH N/A
  • Revenue
  • SWAG $75,893,871.00
  • CYTH $1,132,430.00
  • Revenue This Year
  • SWAG $11.55
  • CYTH N/A
  • Revenue Next Year
  • SWAG N/A
  • CYTH $24.49
  • P/E Ratio
  • SWAG $599.76
  • CYTH N/A
  • Revenue Growth
  • SWAG 28.74
  • CYTH 24.65
  • 52 Week Low
  • SWAG $1.02
  • CYTH $0.59
  • 52 Week High
  • SWAG $1.74
  • CYTH $2.12
  • Technical
  • Relative Strength Index (RSI)
  • SWAG 56.70
  • CYTH 46.91
  • Support Level
  • SWAG $1.10
  • CYTH $0.70
  • Resistance Level
  • SWAG $1.19
  • CYTH $0.77
  • Average True Range (ATR)
  • SWAG 0.04
  • CYTH 0.04
  • MACD
  • SWAG 0.01
  • CYTH -0.00
  • Stochastic Oscillator
  • SWAG 78.50
  • CYTH 28.38

About SWAG Stran & Company Inc.

Stran & Co Inc is an outsourced marketing solutions provider, working closely with customers to develop sophisticated marketing programs that leverage promotional products and loyalty incentive expertise. In addition to selling branded products, It offer its clients with custom sourcing capabilities which is a flexible and customizable e-commerce solution for promoting branded merchandise and other promotional products, managing promotional loyalty and incentives, print collateral, and event assets, order and inventory management, and designing and hosting online retail popup shops. The company purchases products and branding through various third-party manufacturers and decorators and resells the finished goods to customers.

About CYTH Cyclo Therapeutics Inc.

Cyclo Therapeutics Inc is a clinical-stage biotechnology firm. The company is engaged in developing cyclodextrin-based products for treating neurodegenerative diseases, particularly Niemann-Pick Type C disease (NPC). The company's lead drug candidate, Trappsol Cyclo, has undergone clinical trials for NPC treatment. Operating in one segment, the company focuses on developing and commercializing cyclodextrin-based treatments for rare diseases. Revenue primarily comes from selling cyclodextrins and related products to pharmaceutical and nutritional industries, with Trappsol HPB and Trappsol Fine Chemical being significant contributors.

Share on Social Networks: